Portfolio company
Arpeggio Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company provides a transcriptomics platform to map drug effects on gene expression for pharmaceutical and biotechnology partners developing novel therapeutics.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pepper Bio
This company develops transomics software to identify biological targets and drug candidates for pharmaceutical and biotechnology researchers.
Phenomic AI
This company develops a machine learning platform for drug discovery through cell imaging and single-cell RNA sequencing for pharmaceutical and biotechnology partners.
Alithea Genomics
The company produces high-throughput RNA sequencing kits and services for pharmaceutical researchers performing drug discovery, biomarker identification and toxicology screening.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
DropPrint Genomics
This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
Veritas In Silico
The company develops an AI-driven drug discovery platform for identifying mRNA-targeted medicines for pharmaceutical industry partners.
Talus Bio
The company develops a drug discovery platform that identifies transcription factor modulators for pharmaceutical and biotechnology partners seeking to treat cancers and other diseases.
